KBP-5074

Names

[ Name ]:
KBP-5074

Biological Activity

[Description]:

KBP-5074 (KBP5074) is a novel non-steroidal, highly selective mineralocorticoid receptor antagonist for the treatment of hypertensive chronic kidney disease. Other Indication Phase 2 Clinical

[References]

References 1. Granberg K, et al. J Med Chem. 2018 Dec 31. doi: 10.1021/acs.jmedchem.8b01523. View Related Products by Target Mineralocorticoid Receptor (MLR) Other Indication

Chemical & Physical Properties

[ Molecular Formula ]:
C₂₈H₃₀ClN₅O₂

[ Molecular Weight ]:
504.031

Related Compounds

KBP-7018 hydrochloride
KBP-7018
(Z)-GW 5074
CHF5074
GW5074
4-((Cyclohexylamino)methyl)benzoic acid hydrochloride
6,6a(2)-Dibromo[1,1a(2)-biphenyl]-2,2a(2)-dimethanol
2-(5-Nitro-2-furanyl)imidazo[1,2-a]pyrimidine
1-[(2,4-Dichlorophenyl)methyl]-N-(1,1-dimethylethyl)-2-methyl-1H-indole-3-methanamine
2-Methoxy-6-(pyrazol-1-yl)-benzonitrile
1-Phenoxy-2-(trifluoromethyl)benzene
1H-3-Benzazepin-7-ol, 8-chloro-2,3,4,5-tetrahydro-5-(3-iodophenyl)-3-methyl-, (S)-
(4-Methyl-tetrahydro-furan-2-yl)-methanol
N-(1-cyanocyclopentyl)-2-[4-(4-fluorobenzenesulfonyl)-1,4-diazepan-1-yl]acetamide
[(1-Cyanocyclohexyl)(methyl)carbamoyl]methyl 3,4,5-triethoxybenzoate